Congenital iodine deficiency syndrome protruding abdomen. Dwarfism may also be caused by malnutrition or other hormonal deficiencies, such as insufficient growth hormone secretion, hypopituitarism, decreased secretion of growth hormone-releasing hormone, deficient growth hormone receptor activity and downstream causes, such as insulin-like growth factor 1 (IGF-1) deficiency. Sporadic and genetic congenital iodine deficiency syndrome results from abnormal development or growth of the foetal thyroid gland. This type of congenital iodine deficiency has been almost completely eliminated in developed countries by early diagnosis by newborn screening schemes followed by lifelong treatment with thyroxine (T4). Thyroxine must be dosed as tablets only, even to newborns, as the
Tincture of iodine Tincture of iodine Tincture of iodine, iodine tincture, or weak iodine solution is an antiseptic. It is usually 2–7% elemental iodine, along with potassium iodide or sodium iodide, dissolved in a mixture of ethanol and water. Tincture solutions are characterized by the presence of alcohol. It was used from 1908 in pre-operative skin preparation by surgeon Antonio Grossich. In the United Kingdom the development of an iodine solution for skin sterilisation was pioneered by Lionel Stretton. The "British Medical Journal" published the detail of his work at Kidderminster Infirmary in 1909. Stretton used a much weaker solution than that used